EA
WVE icon

Emerald Advisers’s Wave Life Sciences WVE Stock Holding History

Emerald Advisers’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.14M Sell
1,261,183
-1,193,906
-49% -$15.6M 0.29% 104
2025
Q4 		$41.7M Sell
2,455,089
-541,811
-18% -$5.51M 1.29% 18
2025
Q3 		$21.9M Sell
2,996,900
-260,219
-8% -$2.11M 0.7% 60
2025
Q2 		$21.2M Buy
3,257,119
+123,561
+4% +$816K 0.78% 48
2025
Q1 		$25.3M Sell
3,133,558
-28,811
-0.9% -$315K 1.14% 33
2024
Q4 		$39.1M Buy
3,162,369
+280,859
+10% +$3.75M 1.52% 12
2024
Q3 		$23.6M Buy
2,881,510
+388,280
+16% +$2.32M 0.91% 46
2024
Q2 		$12.4M Buy
+2,493,230
New +$14.2M 0.52% 69

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return